Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischemic events after percutaneous coronary intervention: A sub-study of the TWILIGHT trial

Baber, U., Cao, D., Collier, T., Sartori, S., Dangas, G., Angiolillo, D. J., Vogel, B., Kunadian, V., Briguori, C., Cohen, D. J., Dudek, D., Gibson, C. M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Mehta, S., Moliterno, D. J., … Mehran, R. (2024). Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae080
Authors:
Usman Baber
Davide Cao
Timothy Collier
Samantha Sartori
George Dangas
Dominick J Angiolillo
Birgit Vogel
Vijay Kunadian
Carlo Briguori
David J Cohen
Dariusz Dudek
C Michael Gibson
Robert Gil
Kurt Huber
Upendra Kaul
Ran Kornowski
Mitchell W Krucoff
Shamir Mehta
David J Moliterno
E Magnus Ohman
Javier Escaned
Gennaro Sardella
Samin K Sharma
Richard Shlofmitz
Giora Weisz
Bernhard Witzenbichler
P Gabriel Steg
Stuart Pocock
Roxana Mehran
Affiliated Authors:
Giora Weisz
Columbia Affiliation:
Author Keywords:
aspirin
bleeding
pci
recurrent events
thrombosis
ticagrelor monotherapy
elink
Publication Type:
Article
Unique ID:
10.1093/ehjcvp/pvae080
PMID:
39419783
DOI:
10.1093/ehjcvp/pvae080
Journal:
European Heart Journal: Cardiovascular Pharmacotherapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: